Hillcrest Biologicals
Country not established
- Devices
- 33
What Hillcrest Biologicals makes
Hillcrest Biologicals manufactures diagnostic test kits for detecting infectious agents, including herpes simplex, cytomegalovirus (CMV), Mycoplasma pneumoniae, Chlamydia, arboviruses, Lyme disease, polio, and Rickettsia species. Their portfolio includes complement fixation (CF) antigen tests, immunofluorescence assay (IFA) kits, and transport media for Chlamydia samples. These products are designed for laboratory use in identifying specific pathogens via serological or antigen-based methods.
The company’s diagnostic tests are classified under FDA’s Class I and Class II regulatory categories, with some devices requiring 510(k) clearance. Their products are listed in the FDA’s 510(k) database, reflecting their compliance with U.S. medical device regulations. Hillcrest Biologicals operates from the United States.
Catalogue
Search and filter all 33 devicesFrequently asked questions
How many devices does Hillcrest Biologicals have in the registry?
The registry currently lists 33 devices for Hillcrest Biologicals. Devices recorded under merged duplicate company entries are counted once.
Which registries list Hillcrest Biologicals's devices?
Among its 33 most recently registered devices, Hillcrest Biologicals has devices listed in FDA 510(k) (33 devices).
What risk classes do Hillcrest Biologicals's devices fall under?
Among its 33 most recently registered devices, the classes recorded for Hillcrest Biologicals's devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Hillcrest Biologicals in the registry?
The most recently registered devices listed for Hillcrest Biologicals include HERPES-IHA KIT, CMV CF ANTIGEN, MYCOPLASMA PNEUMONIAE CF ANTIGEN and CHLAMYDIA GROUP CF ANTIGEN.